During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.
Featuring:
Fátima Cardoso, MDDirector, Breast UnitChampalimaud Clinical CenterLisbon, Portugal
Mario Campone, MD, PhDChief Executive OfficerInstitut de Cancérologie de l’Ouest (ICO)Angers, France
Giuseppe Viale, MD, FRCPathChairmanDepartment of PathologyUniversity of MilanMilan, Italy
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More